A patient receiving an immune checkpoint inhibitor develops yellow skin, dark urine and marked loss of appetite. Which action is most appropriate?

Correct answer: B. Report the findings promptly for liver-function assessment

  • A. Document the symptoms as expected treatment fatigue
  • B. Report the findings promptly for liver-function assessment
  • C. Encourage a high-fat diet to restore liver energy stores
  • D. Give the next treatment early to control the cancer

Explanation

Jaundice and dark urine may indicate immune-related hepatitis, a potentially serious complication of checkpoint inhibitors. The treatment may need to be withheld and corticosteroid therapy considered after medical assessment, so prompt reporting is required.

Submitted by a TestUstad contributor and published by the TestUstad editorial teamLast updated
Report an error

The more specific you are, the faster it gets fixed. A source beats an opinion.

Prefer email? support@testustad.com

About Oncology Nursing

Covers cancer biology, tumour staging, common malignancies and nursing care during surgery, chemotherapy, radiotherapy, immunotherapy and palliative treatment. It includes managing nausea, pain, fatigue, mucositis, neutropenia and extravasation, while distinguishing expected treatment effects from dangerous complications requiring urgent action.

Practise Oncology Nursing

50 free Oncology Nursing MCQs from Medical Surgical Nursing, each with the correct answer and an explanation. Unlimited attempts, no account needed.

Discussion

Stuck on an option, or know a faster way to get there? Ask or explain it here.

No comments yet. Be the first to explain this one.

Exams that ask Medical Surgical Nursing questions like this

Medical Surgical Nursing is on 8 papers prepared for on TestUstad, and all of them draw the same bank, so this question is worth knowing for every one of them.

More Oncology Nursing questions